While appropriate characterization of GAMM histological staining likely requires context-dependent interpretation (e.g., according to spatial analysis in the TME and by tumor subtype), many studies consistently reported increased CD68 after various forms of therapy [18,19,60]. This evidence concerns the gene CD68 and neoplasm.